Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
482.35
+4.16 (0.87%)
At close: Aug 13, 2025, 4:00 PM
481.94
-0.41 (-0.09%)
After-hours: Aug 13, 2025, 7:58 PM EDT

Company Description

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.

It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.

The company sells its products through direct sales organizations, such as capital and clinical sales teams.

Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical, Inc.
Intuitive Surgical logo
Country United States
Founded 1995
IPO Date Jun 13, 2000
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 15,638
CEO David Rosa

Contact Details

Address:
1020 Kifer Road
Sunnyvale, California 94086-5304
United States
Phone 408 523 2100
Website intuitive.com

Stock Details

Ticker Symbol ISRG
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001035267
CUSIP Number 46120E602
ISIN Number US46120E6023
Employer ID 77-0416458
SIC Code 3842

Key Executives

Name Position
David J. Rosa Chief Executive Officer and Director
Dr. Gary S. Guthart Ph.D. Executive Chair
Jamie E. Samath Chief Financial Officer, Head of Business Technology and Enterprise Technology Leader
Henry L. Charlton Executive Vice President and Chief Commercial and Marketing Officer
Dr. Brian E. Miller Ph.D. Chief Digital Officer
Fredrik Widman Vice President, Principal Accounting Officer and Corporate Controller
Milind Wagle Chief Information Officer
Gary H. Loeb J.D. Chief Legal and Compliance Officer
Dr. Christopher R. Carlson Ph.D. Executive Vice President of Research, Corporate Development, Corporate Strategy and Intuitive Ventures
Patricia Wadors Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Jul 28, 2025 144 Filing
Jul 28, 2025 144 Filing
Jul 25, 2025 144 Filing
Jul 23, 2025 S-8 Securities to be offered to employees in employee benefit plans
Jul 23, 2025 10-Q Quarterly Report
Jul 22, 2025 8-K Current Report
Jun 10, 2025 144 Filing
Jun 6, 2025 144 Filing
Jun 5, 2025 144 Filing
Jun 4, 2025 144 Filing